var singsData = [{"date":new Date(2012,10,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades FFIV to Buy from Neutral. Target Price is $106; previously $104.","showOnAxis":false},{"date":new Date(2012,11,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wedbush maintains FFIV to Outperform. Target Price is $110; previously $95.","showOnAxis":false},{"date":new Date(2012,11,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains FFIV to Neutral. Target Price is $95; previously $83.","showOnAxis":false},{"date":new Date(2012,11,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital initiates coverage on FFIV to Outperform. Target Price is $120.","showOnAxis":false},{"date":new Date(2012,2,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,2,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee maintains FFIV to Buy. Target Price is $141; previously $123.","showOnAxis":false},{"date":new Date(2012,2,28),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"FBN Securities downgrades FFIV to Sector Perform from Outperform. Target Price is $135; previously $125.","showOnAxis":false},{"date":new Date(2012,2,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wedbush maintains FFIV to Outperform. Target Price is $147; previously $125.","showOnAxis":false},{"date":new Date(2012,2,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $127; previously $110.","showOnAxis":false},{"date":new Date(2012,2,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald initiates coverage on FFIV to Hold. Target Price is $145.","showOnAxis":false},{"date":new Date(2012,3,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains FFIV to Overweight. Target Price is $150; previously $125.","showOnAxis":false},{"date":new Date(2012,3,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains FFIV to Neutral. Target Price is $122; previously $120.","showOnAxis":false},{"date":new Date(2012,3,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,3,18),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2012 Q2's earning $0.86 per share and revenue $339.622MM..","showOnAxis":false},{"date":new Date(2012,3,19),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wunderlich upgrades FFIV to Buy from Hold. Target Price is $145; previously $120.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $150; previously $135.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBN Securities maintains FFIV to Sector Perform. Target Price is $155; previously $135.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group maintains FFIV to Buy. Target Price is $150; previously $130.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains FFIV to Neutral. Target Price is $134; previously $122.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains FFIV to Hold. Target Price is $125; previously $112.5.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Miller Tabak maintains FFIV to Buy. Target Price is $165; previously $160.","showOnAxis":false},{"date":new Date(2012,3,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $140; previously $127.","showOnAxis":false},{"date":new Date(2012,3,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $130.","showOnAxis":false},{"date":new Date(2012,3,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley initiates coverage on FFIV to Overweight. Target Price is $155.","showOnAxis":false},{"date":new Date(2012,3,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank oferica maintains FFIV to Buy. Target Price is $145; previously $136.","showOnAxis":false},{"date":new Date(2012,3,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains FFIV to Outperform. Target Price is $150; previously $130.","showOnAxis":false},{"date":new Date(2012,3,9),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades FFIV to Hold from Buy. Target Price is $140.","showOnAxis":false},{"date":new Date(2012,4,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,4,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $140; previously $150.","showOnAxis":false},{"date":new Date(2012,4,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,4,25),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $120; previously $140.","showOnAxis":false},{"date":new Date(2012,5,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains FFIV to Hold. Target Price is $110; previously $145.","showOnAxis":false},{"date":new Date(2012,6,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee maintains FFIV to Buy. Target Price is $121; previously $141.","showOnAxis":false},{"date":new Date(2012,6,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wedbush maintains FFIV to Outperform. Target Price is $117; previously $130.","showOnAxis":false},{"date":new Date(2012,6,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains FFIV to Overweight. Target Price is $125; previously $155.","showOnAxis":false},{"date":new Date(2012,6,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,6,18),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2012 Q3's earning $1.14 per share and revenue $352.6MM. This meets analyst's estimated EPS $1.14, misses estimated revenue $352.86MM.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $136; previously $140.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBN Securities maintains FFIV to Sector Perform. Target Price is $120; previously $155.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains FFIV to Neutral. Target Price is $109; previously $123.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains FFIV to Neutral. Target Price is $99; previously $101.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"McAdams Wright Ragen maintains FFIV to Hold. Target Price is $120; previously $130.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains FFIV to Overweight. Target Price is $130; previously $150.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $110; previously $120.","showOnAxis":false},{"date":new Date(2012,9,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,9,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,15),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2012 Q4's earning $1.12 per share and revenue $362.6MM. This misses analyst's estimated EPS $1.18, misses estimated revenue $365.87MM.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Oppenheimer downgrades FFIV to Perform from Outperform.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Wunderlich downgrades FFIV to Hold from Buy. Target Price is $100; previously $115.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains FFIV to Outperform. Target Price is $115; previously $125.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Equal-Weight. Target Price is $90; previously $105.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $116; previously $136.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBN Securities maintains FFIV to Sector Perform. Target Price is $100; previously $120.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains FFIV to Neutral. Target Price is $100; previously $109.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $90; previously $110.","showOnAxis":false},{"date":new Date(2012,9,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,9,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades FFIV to Equal-Weight from Overweight.","showOnAxis":false},{"date":new Date(2012,9,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades FFIV to Equal-Weight from Overweight. Target Price is $105; previously $115.","showOnAxis":false},{"date":new Date(2012,9,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research initiates coverage on FFIV to Neutral.","showOnAxis":false},{"date":new Date(2013,0,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Needham downgrades FFIV to Hold from Buy.","showOnAxis":false},{"date":new Date(2013,0,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,0,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,0,23),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2013 Q1's earning $1.14 per share and revenue $365.5MM. This misses analyst's estimated EPS $1.15, misses estimated revenue $366.91MM.","showOnAxis":false},{"date":new Date(2013,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains FFIV to Outperform. Target Price is $120; previously $115.","showOnAxis":false},{"date":new Date(2013,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"McAdams Wright Ragen maintains FFIV to Hold. Target Price is $110.","showOnAxis":false},{"date":new Date(2013,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains FFIV to Neutral. Target Price is $104; previously $100.","showOnAxis":false},{"date":new Date(2013,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains FFIV to Overweight. Target Price is $107; previously $106.","showOnAxis":false},{"date":new Date(2013,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $105; previously $90.","showOnAxis":false},{"date":new Date(2013,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains FFIV to Hold. Target Price is $105; previously $100.","showOnAxis":false},{"date":new Date(2013,0,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBN Securities maintains FFIV to Sector Perform. Target Price is $110; previously $100.","showOnAxis":false},{"date":new Date(2013,0,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,0,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,0,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,10,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup initiates coverage on FFIV to Buy. Target Price is $100.","showOnAxis":false},{"date":new Date(2013,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,2,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains FFIV to Neutral. Target Price is $90; previously $105.","showOnAxis":false},{"date":new Date(2013,2,27),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"McAdams Wright Ragen upgrades FFIV to Buy from Hold. Target Price is $110.","showOnAxis":false},{"date":new Date(2013,3,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Baird upgrades FFIV to Outperform from Neutral. Target Price is $110.","showOnAxis":false},{"date":new Date(2013,3,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2013 Q2's earning $1.07 per share and revenue $350.2MM. This meets analyst's estimated EPS $1.07, misses estimated revenue $351.78MM.","showOnAxis":false},{"date":new Date(2013,3,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Nomura upgrades FFIV to Buy from Neutral. Target Price is $88; previously $85.","showOnAxis":false},{"date":new Date(2013,3,26),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"FBR Capital downgrades FFIV to Market Perform from Outperform. Target Price is $75; previously $120.","showOnAxis":false},{"date":new Date(2013,3,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Craig-Hallum initiates coverage on FFIV to Buy. Target Price is $110.","showOnAxis":false},{"date":new Date(2013,3,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,3,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,3,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Citigroup downgrades FFIV to Neutral from Buy. Target Price is $80; previously $125.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"PiperJaffray downgrades FFIV to Neutral from Overweight. Target Price is $82; previously $107.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Topeka downgrades FFIV to Hold from Buy. Target Price is $70; previously $118.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains FFIV to Outperform. Target Price is $80; previously $120.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains FFIV to Buy. Target Price is $98; previously $111.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group maintains FFIV to Buy. Target Price is $95; previously $125.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains FFIV to Hold. Target Price is $82; previously $91.5.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains FFIV to Neutral. Target Price is $85; previously $104.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee maintains FFIV to Buy. Target Price is $95; previously $118.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wedbush maintains FFIV to Outperform. Target Price is $90; previously $112.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains FFIV to Hold. Target Price is $85; previously $105.","showOnAxis":false},{"date":new Date(2013,4,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. initiates coverage on FFIV to Outperform.","showOnAxis":false},{"date":new Date(2013,5,28),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Raymond James upgrades FFIV to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2013,5,3),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades FFIV to Equal-Weight from Overweight.","showOnAxis":false},{"date":new Date(2013,6,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"PiperJaffray upgrades FFIV to Overweight from Neutral.","showOnAxis":false},{"date":new Date(2013,6,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"PiperJaffray upgrades FFIV to Overweight from Neutral. Target Price is $88; previously $80.","showOnAxis":false},{"date":new Date(2013,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"FFIV reports 2013 Q3's earning $1.12 per share and revenue $370.3MM. This beats analyst's estimated EPS $1.08.","showOnAxis":false},{"date":new Date(2013,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":null,"showOnAxis":false},{"date":new Date(2013,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Equal-Weight. Target Price is $89; previously $81.","showOnAxis":false},{"date":new Date(2013,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains FFIV to Buy. Target Price is $97; previously $88.","showOnAxis":false},{"date":new Date(2013,6,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains FFIV to Hold. Target Price is $88; previously $85.","showOnAxis":false},{"date":new Date(2013,7,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades FFIV to Overweight from Equal-Weight. Target Price is $107; previously $89.","showOnAxis":false},{"date":new Date(2013,8,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald initiates coverage on FFIV to Buy. Target Price is $110.","showOnAxis":false},{"date":new Date(2013,8,24),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades FFIV to Neutral from Buy. Target Price is $93.","showOnAxis":false},{"date":new Date(2013,9,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains FFIV to Outperform.","showOnAxis":false},{"date":new Date(2013,9,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,9,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,9,24),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Bank of America downgrades FFIV to Neutral from Buy.","showOnAxis":false},{"date":new Date(2013,9,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $107; previously $100.","showOnAxis":false},{"date":new Date(2013,9,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains FFIV to Buy. Target Price is $100; previously $97.","showOnAxis":false},{"date":new Date(2013,9,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains FFIV to Hold. Target Price is $90; previously $88.","showOnAxis":false},{"date":new Date(2014,0,13),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"William Blair downgrades FFIV to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2014,0,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Nomura downgrades FFIV to Neutral from Buy. Target Price is $111; previously $100.","showOnAxis":false},{"date":new Date(2014,0,22),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Janney Capital upgrades FFIV to Buy from Neutral. Target Price is $122; previously $83.","showOnAxis":false},{"date":new Date(2014,0,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,0,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,0,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,0,23),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"McAdams Wright Ragen downgrades FFIV to Hold from Buy.","showOnAxis":false},{"date":new Date(2014,0,23),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Nomura downgrades FFIV to Neutral from Buy. Target Price is $111; previously $100.","showOnAxis":false},{"date":new Date(2014,0,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains FFIV to Hold. Target Price is $100; previously $90.","showOnAxis":false},{"date":new Date(2014,1,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Dougherty initiates coverage on FFIV to Buy. Target Price is $125.","showOnAxis":false},{"date":new Date(2014,10,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains FFIV to Neutral. Target Price is $130; previously $115.","showOnAxis":false},{"date":new Date(2014,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,3,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"SunTrust Robinson Humphrey initiates coverage on FFIV to Neutral. Target Price is $116.","showOnAxis":false},{"date":new Date(2014,3,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,3,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,3,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades FFIV to Buy from Hold. Target Price is $120.","showOnAxis":false},{"date":new Date(2014,3,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,3,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains FFIV to Neutral. Target Price is $120; previously $112.","showOnAxis":false},{"date":new Date(2014,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Overweight. Target Price is $123; previously $120.","showOnAxis":false},{"date":new Date(2014,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $130.","showOnAxis":false},{"date":new Date(2014,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains FFIV to Neutral. Target Price is $113; previously $111.","showOnAxis":false},{"date":new Date(2014,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains FFIV to Outperform. Target Price is $133; previously $120.","showOnAxis":false},{"date":new Date(2014,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $112; previously $105.","showOnAxis":false},{"date":new Date(2014,3,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Northland initiates coverage on FFIV to Market Perform. Target Price is $113.","showOnAxis":false},{"date":new Date(2014,5,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley initiates coverage on FFIV to Equal-weight.","showOnAxis":false},{"date":new Date(2014,5,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research initiates coverage on FFIV to Neutral. Target Price is $128.","showOnAxis":false},{"date":new Date(2014,6,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,6,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Overweight. Target Price is $126; previously $123.","showOnAxis":false},{"date":new Date(2014,6,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains FFIV to Neutral. Target Price is $112; previously $110.","showOnAxis":false},{"date":new Date(2014,6,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains FFIV to Hold. Target Price is $108.5; previously $101.","showOnAxis":false},{"date":new Date(2014,6,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains FFIV to Neutral. Target Price is $114; previously $112.","showOnAxis":false},{"date":new Date(2014,6,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"D.A. Davidson initiates coverage on FFIV to Buy. Target Price is $145.","showOnAxis":false},{"date":new Date(2014,7,19),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"ISI Group upgrades FFIV to Strong Buy from Buy.","showOnAxis":false},{"date":new Date(2014,8,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $150; previously $135.","showOnAxis":false},{"date":new Date(2014,8,29),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Baird downgrades FFIV to Neutral from Outperform. Target Price is $125.","showOnAxis":false},{"date":new Date(2014,9,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse initiates coverage on FFIV to Outperform. Target Price is $140.","showOnAxis":false},{"date":new Date(2014,9,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains FFIV to Equal-Weight. Target Price is $113.","showOnAxis":false},{"date":new Date(2014,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,9,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Overweight. Target Price is $136; previously $126.","showOnAxis":false},{"date":new Date(2014,9,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cantor Fitzgerald maintains FFIV to Buy. Target Price is $145; previously $134.","showOnAxis":false},{"date":new Date(2014,9,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains FFIV to Hold. Target Price is $115; previously $108.5.","showOnAxis":false},{"date":new Date(2014,9,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains FFIV to Neutral. Target Price is $118; previously $113.","showOnAxis":false},{"date":new Date(2014,9,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains FFIV to Buy. Target Price is $135; previously $120.","showOnAxis":false},{"date":new Date(2014,9,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains FFIV to Neutral. Target Price is $138; previously $120.","showOnAxis":false},{"date":new Date(2015,0,14),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades FFIV to Equal-Weight from Overweight. Target Price is $136.","showOnAxis":false},{"date":new Date(2015,0,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,0,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,0,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades FFIV to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,0,22),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Buckingham Research upgrades FFIV to Buy from Neutral.","showOnAxis":false},{"date":new Date(2015,0,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Equal-Weight. Target Price is $114; previously $136.","showOnAxis":false},{"date":new Date(2015,0,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $140; previously $150.","showOnAxis":false},{"date":new Date(2015,0,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains FFIV to Buy. Target Price is $122; previously $135.","showOnAxis":false},{"date":new Date(2015,0,5),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Oppenheimer upgrades FFIV to Outperform from Market Perform. Target Price is $160.","showOnAxis":false},{"date":new Date(2015,0,6),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Needham downgrades FFIV to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,10,13),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"JMP Securities downgrades FFIV to Market Perform from Market Outperform.","showOnAxis":false},{"date":new Date(2015,10,13),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"William Blair downgrades FFIV to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,11,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,11,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,11,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,9),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Nomura downgrades FFIV to Reduce from Neutral. Target Price is $90.","showOnAxis":false},{"date":new Date(2015,2,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,2,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,2,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wedbush initiates coverage on FFIV to Outperform. Target Price is $140.","showOnAxis":false},{"date":new Date(2015,2,9),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades FFIV to Underperform from Equal-Weight. Target Price is $114.","showOnAxis":false},{"date":new Date(2015,3,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,3,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,3,23),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"MKM Partners downgrades FFIV to Neutral from Buy.","showOnAxis":false},{"date":new Date(2015,3,23),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Needham upgrades FFIV to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,3,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $140.","showOnAxis":false},{"date":new Date(2015,3,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains FFIV to Overweight. Target Price is $149; previously $141.","showOnAxis":false},{"date":new Date(2015,3,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains FFIV to Overweight. Target Price is $130; previously $128.","showOnAxis":false},{"date":new Date(2015,5,1),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Citigroup downgrades FFIV to Neutral from Buy. Target Price is $132; previously $122.","showOnAxis":false},{"date":new Date(2015,5,28),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"PiperJaffray downgrades FFIV to Neutral from Overweight. Target Price is $130.","showOnAxis":false},{"date":new Date(2015,5,29),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"PiperJaffray downgrades FFIV to Neutral from Overweight. Target Price is $130.","showOnAxis":false},{"date":new Date(2015,5,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura initiates coverage on FFIV to Neutral. Target Price is $118.","showOnAxis":false},{"date":new Date(2015,6,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,22),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,6,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains FFIV to Outperform. Target Price is $140; previously $127.","showOnAxis":false},{"date":new Date(2015,6,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains FFIV to Outperform. Target Price is $133; previously $145.","showOnAxis":false},{"date":new Date(2015,7,3),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Buckingham Research downgrades FFIV to Neutral from Buy.","showOnAxis":false},{"date":new Date(2015,7,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Buy. Target Price is $145; previously $140.","showOnAxis":false},{"date":new Date(2015,8,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Guggenheim downgrades FFIV to Neutral.","showOnAxis":false},{"date":new Date(2015,8,25),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Raymond James downgrades FFIV to Market Perform.","showOnAxis":false},{"date":new Date(2015,9,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays initiates coverage on FFIV to Equal-Weight. Target Price is $131.","showOnAxis":false},{"date":new Date(2015,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,29),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"BMO Capital downgrades FFIV to Market Perform from Outperform. Target Price is $108; previously $140.","showOnAxis":false},{"date":new Date(2015,9,29),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Needham downgrades FFIV to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,9,29),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"RBC Capital downgrades FFIV to Sector Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,9,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Equal-Weight. Target Price is $123; previously $131.","showOnAxis":false},{"date":new Date(2015,9,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities maintains FFIV to Market Outperform. Target Price is $125; previously $135.","showOnAxis":false},{"date":new Date(2015,9,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup initiates coverage on FFIV to Sell. Target Price is $105.","showOnAxis":false},{"date":new Date(2016,0,12),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Deutsche Bank downgrades FFIV to Hold from Buy.","showOnAxis":false},{"date":new Date(2016,0,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains FFIV to Overweight. Target Price is $109; previously $149.","showOnAxis":false},{"date":new Date(2016,0,14),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades FFIV to Underweight from Equal-Weight. Target Price is $98; previously $123.","showOnAxis":false},{"date":new Date(2016,0,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains FFIV to Sector Perform. Target Price is $112; previously $115.","showOnAxis":false},{"date":new Date(2016,0,15),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Sterne Agee CRT downgrades FFIV to Neutral from Buy.","showOnAxis":false},{"date":new Date(2016,0,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,0,20),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2016 Q1's earning $1.73 per share and revenue $489.486MM. This beats analyst's estimated EPS $1.6, beats estimated revenue $485.62MM.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains FFIV to Market Perform. Target Price is $93; previously $108.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Underweight. Target Price is $96; previously $98.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research maintains FFIV to Neutral. Target Price is $105; previously $110.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Hold. Target Price is $95; previously $100.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains FFIV to Hold. Target Price is $100; previously $115.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"SunTrust Robinson Humphrey maintains FFIV to Neutral. Target Price is $110; previously $115.","showOnAxis":false},{"date":new Date(2016,0,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,0,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains FFIV to Overweight. Target Price is $5; previously $11.","showOnAxis":false},{"date":new Date(2016,10,30),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Bernstein downgrades FFIV to Market Perform from Outperform. Target Price is $140.","showOnAxis":false},{"date":new Date(2016,10,9),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Nomura upgrades FFIV to Neutral from Reduce. Target Price is $130; previously $115.","showOnAxis":false},{"date":new Date(2016,11,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Citigroup upgrades FFIV to Buy from Neutral.","showOnAxis":false},{"date":new Date(2016,2,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,3,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,3,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,3,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,3,20),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2016 Q2's earning $1.68 per share and revenue $483.677MM. This beats analyst's estimated EPS $1.63, misses estimated revenue $485.93MM.","showOnAxis":false},{"date":new Date(2016,3,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird maintains FFIV to Neutral. Target Price is $110; previously $105.","showOnAxis":false},{"date":new Date(2016,3,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research maintains FFIV to Neutral. Target Price is $107; previously $105.","showOnAxis":false},{"date":new Date(2016,3,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains FFIV to Neutral. Target Price is $110; previously $95.","showOnAxis":false},{"date":new Date(2016,3,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains FFIV to Hold. Target Price is $99; previously $95.","showOnAxis":false},{"date":new Date(2016,3,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains FFIV to Neutral. Target Price is $119; previously $111.","showOnAxis":false},{"date":new Date(2016,4,17),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Pacific Crest downgrades FFIV to Sector Weight from Overweight.","showOnAxis":false},{"date":new Date(2016,6,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,6,20),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2016 Q3's earning $1.81 per share and revenue $496.522MM. This beats analyst's estimated EPS $1.79, beats estimated revenue $495.29MM.","showOnAxis":false},{"date":new Date(2016,6,21),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Credit Suisse downgrades FFIV to Neutral from Outperform. Target Price is $125.","showOnAxis":false},{"date":new Date(2016,7,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,7,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"DA Davidson maintains FFIV to Buy. Target Price is $145; previously $125.34.","showOnAxis":false},{"date":new Date(2016,7,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,8,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Oppenheimer upgrades FFIV to Outperform from Perform.","showOnAxis":false},{"date":new Date(2016,8,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,8,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,9,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2016 Q4's earning $2.11 per share and revenue $525.349MM. This beats analyst's estimated EPS $1.94, beats estimated revenue $520.45MM.","showOnAxis":false},{"date":new Date(2016,9,27),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"PiperJaffray upgrades FFIV to Overweight from Neutral.","showOnAxis":false},{"date":new Date(2016,9,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains FFIV to Neutral.","showOnAxis":false},{"date":new Date(2016,9,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains FFIV to Hold.","showOnAxis":false},{"date":new Date(2017,0,25),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, FFIV reports 2017 Q1's earning $1.98 per share and revenue $515.958MM. This beats analyst's estimated EPS $1.94, misses estimated revenue $517.97MM.","showOnAxis":false}];